Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

MANGIFERIN CRS (15 MG)

MANGIFERIN CRS (15 MG)

4773-96-0

DISCOVER
INDIGO CRS (15 MG)

INDIGO CRS (15 MG)

482-89-3

DISCOVER
ANEMARRHENA RHIZOME FOR SYSTEM SUITABILITY HRS (150 MG)

ANEMARRHENA RHIZOME FOR SYSTEM SUITABILITY HRS (150 MG)

NA

DISCOVER
FLUTICASONE PROPIONATE FOR IMPURITY C IDENTIFICATION CRS (5

FLUTICASONE PROPIONATE FOR IMPURITY C IDENTIFICATION CRS (5

80474-14-2

DISCOVER
Fluticasone propionate for impurity G identification CRS, 5mg

Fluticasone propionate for impurity G identification CRS, 5mg

80474-14-2

DISCOVER
EXEMESTANE FOR SYSTEM SUITABILITY CRS (10 MG)

EXEMESTANE FOR SYSTEM SUITABILITY CRS (10 MG)

107868-30-4

DISCOVER
BROMHEXINE FOR SYSTEM SUITABILITY CRS (15 MG)

BROMHEXINE FOR SYSTEM SUITABILITY CRS (15 MG)

611-75-6

DISCOVER
THIAMINE NITRATE CRS (15 MG)

THIAMINE NITRATE CRS (15 MG)

532-43-4

DISCOVER
METHYLPREDNISOLONE HYDROGEN SUCCINATE FOR PEAK IDENTIFICATIO

METHYLPREDNISOLONE HYDROGEN SUCCINATE FOR PEAK IDENTIFICATIO

2921-57-5

DISCOVER
METHYLPREDNISOLONE ACETATE FOR SYSTEM SUITABILITY CRS (10 MG

METHYLPREDNISOLONE ACETATE FOR SYSTEM SUITABILITY CRS (10 MG

53-36-41

DISCOVER
NICORANDIL CRS (5 MG)

NICORANDIL CRS (5 MG)

65141-46-0

DISCOVER
NICORANDIL IMPURITY A CRS (5 MG)

NICORANDIL IMPURITY A CRS (5 MG)

NA

DISCOVER